Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olalekan Uthman

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Health Technology Assessment (Winchester, England)|January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Plos One|August 23, 2018
Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort studyYohanna Kambai Avong, Bolajoko Jatau, Ritmwa Gurumnaan, et al.
Journal of the American College of Cardiology|May 22, 2017
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015Gregory A Roth, Catherine Johnson, Amanuel Abajobir, et al.
JAMA Pediatrics|April 7, 2017
Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study, Nicholas Kassebaum, Hmwe Hmwe Kyu, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Health Technology Assessment (Winchester, England)|January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Plos One|August 23, 2018
Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort studyYohanna Kambai Avong, Bolajoko Jatau, Ritmwa Gurumnaan, et al.
Journal of the American College of Cardiology|May 22, 2017
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015Gregory A Roth, Catherine Johnson, Amanuel Abajobir, et al.
JAMA Pediatrics|April 7, 2017
Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study, Nicholas Kassebaum, Hmwe Hmwe Kyu, et al.
Pageof 4